Neither LRP-1 or CALR have been investigated in OSA before, despite that intermittent hypoxaemia, altered metabolism and systemic inflammation may change their levels, and these molecules have also the potential to affect these processes. The gene discussed is LRP1; the disease is obstructive sleep apnea syndrome.